Professor Josh Davis
Senior principal research fellow
Qualifications:
PhD, Charles Darwin University, 2011
Bachelor of Medicine and Bachelor of Surgery, University of Sydney, 1994
Diploma of Tropical Medicine and Hygiene, University of Liverpool (UK), 1998
Graduate Diploma of Population Health, University of Newcastle, 2008
Fellow of the Royal Australasian College of Physicians in Infectious Diseases, 2005
Approved level of HDR supervision at Charles Darwin University:
Principal Supervisor for PhD
Location:
Biography:
Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main research interests are clinical trials in the management of severe infections, epidemiology of severe bacterial infections, and the clinical and molecular epidemiology of viral hepatitis.
Josh is the clinical lead for viral hepatitis for the Hunter New England local health district in NSW, and the clinical lead for the COVID-19 expert reference group for the Hunter New England local health district.
In 2018, Josh was awarded a research excellence award from the NHMRC for the top ranked career development fellowship, and he is a chief investigator on several ongoing large multinational RCTs including SNAP (adaptive platform trial assessing multiple treatments for Staph aureus bacteraemia), ASCOT (adaptive platform trial of therapeutic agents for COVID-19), BLING3 (RCT of continuous infusion versus bolus dosing of antibiotics in ICU) and SUDDICU (Cluster cross-over RCT of selective digestive tract decontamination in ICU). He also established and is the co-lead of the Menzies Viral Hepatitis Research Program.
.PNG&w=123&h=126)
.jpg&w=123&h=126)
